Premium Information is available for this item - Upgrade for $1 a day
6505-01-101-8922
Usp Pancrelipase Tablets
6505011018922 011018922 ILOZYME NDC00013-2001-19
January 2023
6
Marketplace 6505-01-101-8922
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-101-8922 5+ Documents (More...)
/fsg-65/fsc-6505/us
Stock Usp Pancrelipase Tablets 6505011018922 Usp 6505011018922 Stock Usp Pancrelipase Tablets 6505011018922
/fsg-65/fsc-6505/us 6505-01-101-8922 Usp Pancrelipase Tablets 6505011018922 1980 Data Last Changed January
/fsg-65/fsc-6505/us
Tablets 6505011018922 Tablets Usp 6505011018922 Usp 6505011018922 Stock Usp Pancrelipase Tablets 6505011018922
8922 6505-01-080-2377 Usp Pancrelipase Tablets 6505010802377 Usp Pancrelipase Tablets 6505011018922
/fsg-65/fsc-6505/us
Tablets 6505011018922 6505011018922 8922 6505-01-080-2377 6505-01- 101-8922 https//www.nsnlookup.com
6505-01-352-2389 https 6505011018922 1980 Data Last Changed January on 8 Oct 1980 Usp Pancrelipase
Usp Pancrelipase Tablets 6505011018922 Pancrelipase Tablets 6505370800018370800018 Usp Pancrelipase
Tablets 65050135223896505-01-352- Pancrelipase Tablets 6505370800018370800018 6505-01-101-8922 www.nsnlookup.com
/fsg-65/fsc-6505/us
240-3834 Usp Pancrelipase Tablets 6505012403834 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-101-8922
Usp Pancrelipase Tablets 6505011018922 /www.nsnlookup.com https 6505370800018370800018 https//www.nsnlookup.com
Restrictions 6505-01-101-8922
6505-01-101-8922 is a Usp Pancrelipase Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-101-8922
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-101-8922
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-101-8922
- Part Number
- Manufacturer
- Status
- NDC00013-2001-19
- Manufacturer
- 58750 - Erbamont Inc Adria Laboratories Div (Active)
- Primary Buy
- Primary Buy
- ILOZYME
- 58750 - Erbamont Inc Adria Laboratories Div (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-101-8922
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 30000.000 Usp Units Amylase Active Ingredient And 11000.000 Usp Units Lipase Active Ingredient And 30000.000 Usp Units Protease Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Content Quantity [CRLK]
- 250.000 Tablets
- Primary Container Type [CQCT]
- Bottle
Management Data 6505-01-101-8922
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Nov 1983
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 250 Tt
- 00000000250TT
- K
NATO Stock Numbers Related to 6505-01-101-8922
Freight Information 6505-01-101-8922
6505-01-101-8922 has freight characteristics.. 6505-01-101-8922 has a variance between NMFC and UFC when transported by rail and the description should be consulted.